In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model

Nephrology Dialysis Transplantation

Volumn 22, Issue 8, 2007, Pages 2239-2246

  LaPlante, Kerry L ^a,b,d   Mermel, Leonard A ^b,c  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Biofilms; Catheter lock solutions; Daptomycin; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin

Indexed keywords

CALCIUM CARBONATE; DAPTOMYCIN; HEPARIN; VANCOMYCIN;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOFILM; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EXPOSURE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BIOFILMS; CALCIUM CARBONATE; CATHETERIZATION, CENTRAL VENOUS; DAPTOMYCIN; EQUIPMENT CONTAMINATION; EQUIPMENT FAILURE; REFERENCE VALUES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STERILIZATION; TIME FACTORS; VANCOMYCIN;

EID: 34547913104     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm141     Document Type: Article

References (41)

1. Turakhia MH. The Influence of Calcium on Biofilm Processes. Bozeman, Montana State University: 1986
2. Akiyama H, Huh WK, Yamasaki O, Oono T, Iwatsuki K. Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in mouse skin: Does S. aureus generally produce a biofilm on damaged skin? Br J Dermatol 2002; 147: 879-885
3. Ozerdem Akpolat N, Elci S, Atmaca S, Akbayin H, Gul K. The effects of magnesium, calcium and EDTA on slime production by Staphylococcus epidermidis strains. Folia Microbiol (Praha) 2003; 48: 649-653
4. Beenken KE, Dunman PM, McAleese F et al. Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 2004; 186: 4665-4684
5. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 2004; 186: 1838-1850
6. Mermel LA, Farr BM, Sheretz RJ et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-1272
7. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J 2000; 46: S47-S52
8. Donlan RM, Murga R, Bell M et al. Protocol for detection of biofilms on needleless connectors attached to central venous catheters. J Clin Microbiol 2001; 39: 750-753
9. Gotz F. Staphylococcus and biofilms. Mol Microbiol 2002; 43: 1367-1378
10. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis 2001; 7: 277-281
11. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23: 759-769
12. Dvorchik B. Moderate liver impairment has no influence on daptomycin pharmacokinetics. J Clin Pharmacol 2004; 44: 715-722
13. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 2003; 47: 3145-3148
14. Shah CB, Mittelman MW, Costerton JW et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002; 46: 1674-1679
15. Wilcox MH, Kite P, Mills K, Sugden S. In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm. J Antimicrob Chemother 2001; 47: 171-175
16. El-Azizi M, Rao S, Kanchanapoom T, Khardori N. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann Clin Microbiol Antimicrob 2005; 4: 2
17. Gander S, Hayward K, Finch R. An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. J Antimicrob Chemother 2002; 49: 301-308
18. Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother 2005; 55: 792-795
19. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-1776
20. Oie S, Huang Y, Kamiya A, Konishi H, Nakazawa T. Efficacy of disinfectants against biofilm cells of methicillin-resistant Staphylococcus aureus. Microbios 1996; 85: 223-230
21. Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 2538-2544
22. LaPlante KL, Rybak MJ. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2004; 48: 4665-4672
23. Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 2003; 47: 3407-3414
24. National Committee for Clinical Laboratory Standards, 2004. Approved standard M7-A6: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th Wayne, PA: 2004
25. Wise R, Andrews JM, Ashby JP. Activity of daptomycin against Gram-positive pathogens: A comparison with other agents and the determination of a tentative breakpoint. J Antimicrob Chemother 2001; 48: 563-567
26. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement. In: M100-S16. In: Clinical Laboratory Standards Institute (Formerly NCCLS), 16th edn, Vol. 26, Wayne, PA: 2006
27. Christensen GD, Simpson WA, Younger JJ et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985; 22: 996-1006
28. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 2000; 40: 175-179
29. Krishnasami Z, Carlton D, Bimbo L et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61: 1136-1142
30. Lai JJ, Brodeur SK. Physical and chemical compatibility of daptomycin with nine medications. Ann Pharmacother 2004; 38: 1612-1616
31. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132: 391-402. Erratum in: 2000, Ann Intern Med 2005: 2133
32. Vaudaux P, Francois P, Bisognano C, Li D, Lew DP, Schrenzel J. Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus. J Antimicrob Chemother 2003; 52: 89-95
33. Lee JY, Ko KS, Peck KR, Oh WS, Song JH. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J Antimicrob Chemother 2006; 57: 1110-1115
34. Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 2006; 50: 1865-1868
35. Giacometti A, Cirioni O, Ghiselli R et al. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother 2005; 49: 4042-4045
36. Shanks RM, Donegan NP, Graber ML. Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 2005; 73: 4596-4606
37. Skiest DJ. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol 2006; 44: 655-656
38. Hayden MK, Rezai K, Hayes RA, Lolans K, Quinn JP, Weinstein RA. Development of Daptomycin resistance in vivo in methicillin-resistant. Staphylococcus aureus. J Clin Microbiol 2005; 43: 5285-5287
39. From the Centers for Disease Control and Prevention, 2002: Vancomycin resistant Staphylococcus aureus, Pennsylvania, 2002; 288: 2116
40. Vancomycin-resistant Staphylococcus aureus - New York, 2004. MMWR Morb Mortal Wkly Rep 2004; 53: 322-323
41. Michigan Department of Community Health; March, 3, 2005.